Cohort studies (and skin cancer) never come alone.

Autor:	Verkouteren JAC; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., van der Leest RJT; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Nijsten T; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. Electronic address: t.nijsten@erasmusmc.nl.
Jazyk:	angličtina
Zdroj:	The Journal of investigative dermatology [J Invest Dermatol] 2015 Mar; Vol. 135 (3), pp. 649-651.
DOI:	10.1038/jid.2014.482
Abstrakt:	A previous keratinocyte carcinoma is probably the strongest predictor of developing new keratinocyte carcinomas, which makes these patients an interesting population for prevention interventions. Investing in large cohort studies and consortia might increase the validity of observational findings and should stimulate scientists to investigate the underlying mechanisms in detail.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu